|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2002-7-19
|
|
pubmed:abstractText |
Two programs to reduce expenditures for common gastrointestinal drugs were introduced simultaneously by British Columbia (BC) Pharmacare in 1995. Reference-based pricing restricted reimbursement for all histamine-2 receptor antagonists (H2RAs) to the cost of the least expensive H2RA available, generic cimetidine. Special authority restricted reimbursement for proton pump inhibitors (PPIs) to patients who met certain eligibility criteria. We evaluated the effect of reference-based pricing for H2RAs and special authority for PPIs on dispensing and reimbursement for senior citizen beneficiaries of BC Pharmacare.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/12126319-10344913,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12126319-10463048,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12126319-10463052,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12126319-10750472,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12126319-10870511,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12126319-11003807,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12126319-12427695,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12126319-1978250,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12126319-9101000,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12126319-9178669,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12126319-9520957,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12126319-9803991,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12126319-9926265
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0820-3946
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
25
|
|
pubmed:volume |
166
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1655-62
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia.
|
|
pubmed:affiliation |
Department of Medicine, McMaster University, Hamilton, Ont. marshllj@mcmaster.ca
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
